Cooper Consumer Health Acquires Viatris' Over-the-Counter Business
July 3, 2024
Cooper Consumer Health has completed the acquisition of the Over-the-Counter (OTC) business of Viatris Inc., following regulatory approvals and worker council consultations. The deal brings more than 200 brands (including Betadine, Saugella, Armolipid and CB12), two manufacturing sites in Mérignac (France) and Confienza (Italy) and an R&D centre in Monza (Italy) into Cooper's platform, doubling Cooper's revenues to approximately €1.2bn.
- Buyers
- Cooper Consumer Health
- Targets
- Viatris Inc. Over-the-Counter (OTC) business
- Sellers
- Viatris Inc.
- Industry
- Pharmaceuticals
- Location
- Pennsylvania, United States
- Transaction Type
- Divestiture
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.